MIST: Milestone Pharmaceuticals Inc. Stock

by  •  • Comments Off on MIST: Milestone Pharmaceuticals Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 109.38
Enterprise Value ($M) 137.41
Book Value ($M) 13.15
Book Value / Share 0.25
Price / Book 8.32
NCAV ($M) 11.57
NCAV / Share 0.22
Price / NCAV 9.45

Profitability (mra)
Return on Invested Capital (ROIC) -0.61
Return on Assets (ROA) -0.55
Return on Equity (ROE) -2.48

Liquidity (mrq)
Quick Ratio 9.10
Current Ratio 9.10

Balance Sheet (mrq) ($M)
Current Assets 73.93
Assets 75.50
Liabilities 62.35
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -42.10
Net Income -41.52
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -28.85
Cash from Investing 8.28
Cash from Financing 32.12

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-14 13G/A Rtw Investments, Lp 9.99 68.13
02-05 13G/A BlackRock, Inc. 7.60 23.85
10-29 13G/A Integrated Core Strategies (us) Llc 5.20 60.53
07-16 13D/A Alta Fundamental Advisers LLC 4.99 59.07

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-03-13 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 ☐ TRANSITION REPORT PURSUA
2024-11-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-08-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-05-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-04-29 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1) (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 ¨ TRAN

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-03-25 1,121,457 3,026,437 37.06
2025-03-24 1,010,742 3,337,588 30.28
2025-03-21 850,680 2,172,727 39.15

(click for more detail)

Similar Companies
MDGL – Madrigal Pharmaceuticals, Inc. MGNX – MacroGenics, Inc.
MGTX – MeiraGTx Holdings plc MLYS – Mineralys Therapeutics, Inc.
MNMD – Mind Medicine (MindMed) Inc.


Financial data and stock pages provided by
Fintel.io